One of the areas of interest is targeting AHR in cancer (Paris et al, 2021), albeit the role of AHR in cancers is ambiguous as there is evidence for a tumour-suppressive role as well as potential involvement in tumour progression (Murray et al, 2014). The gene discussed is AHR; the disease is neoplasm.